Compare BXC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BXC | ANGO |
|---|---|---|
| Founded | 2004 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.7M | 550.8M |
| IPO Year | 2004 | 2004 |
| Metric | BXC | ANGO |
|---|---|---|
| Price | $62.05 | $12.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $88.67 | $19.33 |
| AVG Volume (30 Days) | 97.0K | ★ 417.7K |
| Earning Date | 02-17-2026 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $2,948,840,000.00 | $300,718,000.00 |
| Revenue This Year | $0.63 | $8.18 |
| Revenue Next Year | $3.06 | $5.15 |
| P/E Ratio | $36.48 | ★ N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $52.71 | $8.27 |
| 52 Week High | $114.19 | $13.99 |
| Indicator | BXC | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 48.26 |
| Support Level | $60.02 | $13.12 |
| Resistance Level | $62.97 | $13.91 |
| Average True Range (ATR) | 2.40 | 0.37 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 41.72 | 1.90 |
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.